4//SEC Filing
Holsinger Leslie 4
Accession 0001209191-20-063615
CIK 0001662774other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:17 PM ET
Size
22.1 KB
Accession
0001209191-20-063615
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
Holsinger Leslie
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2020-12-14$0.27/sh+40,000$10,800→ 43,500 total - Sale
Common Stock
2020-12-14$28.80/sh−1,700$48,960→ 41,800 total - Sale
Common Stock
2020-12-14$30.15/sh−14,275$430,391→ 27,525 total - Sale
Common Stock
2020-12-14$30.91/sh−13,200$408,012→ 14,325 total - Sale
Common Stock
2020-12-14$31.79/sh−9,525$302,800→ 1,800 total - Sale
Common Stock
2020-12-14$32.59/sh−400$13,034→ 4,400 total - Sale
Common Stock
2020-12-14$32.59/sh−900$29,331→ 3,500 total - Award
Stock Option (Right to Buy)
2020-12-11+100,000→ 100,000 totalExercise: $29.60Exp: 2030-12-10→ Common Stock (100,000 underlying) - Award
Stock Option (Right to Buy)
2020-12-11+100,000→ 100,000 totalExercise: $29.60Exp: 2030-12-10→ Common Stock (100,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-14−40,000→ 66,794 totalExercise: $0.27Exp: 2026-05-09→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 29, 2020.
- [F2]The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date, subject to the grantee's continuous service to the Issuer on each such date.
- [F3]50% of the shares will vest on March 31, 2023 provided that the Issuer's Compensation Committee has determined that Performance Condition No. 1 (as defined below) has been met, and 50% of the shares will vest on March 31, 2024 provided that the Issuer's Compensation Committee has determined that Performance Condition No. 2 (as defined below) has been met; provided further that, in each case, the grantee will have been continuously a service provider from the date of grant through each such vesting date. Performance Condition No. 1 means that the average closing price per share of the Issuer's common stock in any 45 consecutive trading day period prior to March 15, 2023 has exceeded $135 per share. Performance Condition No. 2 means that the average closing price per share of the Issuer's common stock in any 45 consecutive trading day period prior to March 15, 2024 has exceeded $170 per share.
- [F4]The option vested at the rate of 25% of the shares on April 4, 2017, and the remaining 75% of shares vested in equal monthly installments beginning on May 4, 2017 until all the shares were fully vested on April 4, 2020.
Documents
Issuer
Cortexyme, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001770821
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 7:17 PM ET
- Size
- 22.1 KB